IRadimed Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook, Reaffirms 2026 Guidance

MT Newswires Live07-31

IRadimed (IRMD) reported Q2 non-GAAP earnings Friday of $0.46 per diluted share, compared with $0.49 a year earlier.

Two analysts polled by FactSet expected $0.44.

Revenue for the quarter ended June 30 was $20.5 million, compared with $20.4 million a year earlier.

Two analysts surveyed by FactSet expected $20.4 million.

The company said it expects Q3 adjusted earnings per share of $0.54 to $0.59, along with revenue of $23 million to $24.5 million.

Two analysts expect $0.54 and $23.7 million, respectively.

For the full year, IRadimed continues to expect adjusted earnings per share of $2.09 to $2.24 and revenue of $91 million to $96 million.

Two analysts expect $2.08 and $91.2 million, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2655369838?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 20:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2655369838","market":"sh","top_or_hot":-1,"title":"IRadimed Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook, Reaffirms 2026 Guidance","media":"MT Newswires Live","content":"<html><body><p> IRadimed (IRMD) reported Q2 non-GAAP earnings Friday of $0.46 per diluted share, compared with $0.49 a year earlier.</p><p>Two analysts polled by FactSet expected $0.44.</p><p>Revenue for the quarter ended June 30 was $20.5 million, compared with $20.4 million a year earlier.</p><p>Two analysts surveyed by FactSet expected $20.4 million.</p><p>The company said it expects Q3 adjusted earnings per share of $0.54 to $0.59, along with revenue of $23 million to $24.5 million.</p><p>Two analysts expect $0.54 and $23.7 million, respectively.</p><p>For the full year, IRadimed continues to expect adjusted earnings per share of $2.09 to $2.24 and revenue of $91 million to $96 million.</p><p>Two analysts expect $2.08 and $91.2 million, respectively.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IRadimed Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook, Reaffirms 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIRadimed Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook, Reaffirms 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-31 20:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> IRadimed (IRMD) reported Q2 non-GAAP earnings Friday of $0.46 per diluted share, compared with $0.49 a year earlier.</p><p>Two analysts polled by FactSet expected $0.44.</p><p>Revenue for the quarter ended June 30 was $20.5 million, compared with $20.4 million a year earlier.</p><p>Two analysts surveyed by FactSet expected $20.4 million.</p><p>The company said it expects Q3 adjusted earnings per share of $0.54 to $0.59, along with revenue of $23 million to $24.5 million.</p><p>Two analysts expect $0.54 and $23.7 million, respectively.</p><p>For the full year, IRadimed continues to expect adjusted earnings per share of $2.09 to $2.24 and revenue of $91 million to $96 million.</p><p>Two analysts expect $2.08 and $91.2 million, respectively.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RGLO","symbol_name":"Global Equity Active ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2655369838","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2655369838","pubTimestamp":1785501180,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"IRadimed  reported Q2 non-GAAP earnings Friday of $0.46 per diluted share, compared with $0.49 a year earlier.Two analysts polled by FactSet expected $0.44.Revenue for the quarter ended June 30 was $20.5 million, compared with $20.4 million a year earlier.Two analysts surveyed by FactSet expected $20.4 million.The company said it expects Q3 adjusted earnings per share of $0.54 to $0.59, along with revenue of $23 million to $24.5 million.Two analysts expect $0.54 and $23.7 million, respectively.For the full year, IRadimed continues to expect adjusted earnings per share of $2.09 to $2.24 and revenue of $91 million to $96 million.Two analysts expect $2.08 and $91.2 million, respectively.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RGLO":"Global Equity Active ETF","BK4082":"医疗保健设备","JOYT":"JPMorgan Equity and Options Total Return ETF","DECU":"AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF","VOTE":"TCW Transform 500 ETF","GXDW":"Global X Dorsey Wright Thematic ETF","VGFPF":"Vanguard Funds PLC","IRMD":"iRadimed Corporation","FEBU":"AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF","PMDE":"PGIM S&P 500 Max Buffer ETF - December"},"translate_title":"IRadimed Q2调整后盈利下降，收入增长；发布第三季度展望，重申 2026 年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGLO":0.67,"JOYT":0.67,"VGFPF":0.67,"PMDE":0.67,"IRMD":1,"VOTE":0.67,"DECU":0.67,"GXDW":0.67,"FEBU":0.67},"content_text":"IRadimed (IRMD) reported Q2 non-GAAP earnings Friday of $0.46 per diluted share, compared with $0.49 a year earlier.Two analysts polled by FactSet expected $0.44.Revenue for the quarter ended June 30 was $20.5 million, compared with $20.4 million a year earlier.Two analysts surveyed by FactSet expected $20.4 million.The company said it expects Q3 adjusted earnings per share of $0.54 to $0.59, along with revenue of $23 million to $24.5 million.Two analysts expect $0.54 and $23.7 million, respectively.For the full year, IRadimed continues to expect adjusted earnings per share of $2.09 to $2.24 and revenue of $91 million to $96 million.Two analysts expect $2.08 and $91.2 million, respectively.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2655369838","isCrawlerRequest":true}